Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aloe Vera Gel as Intracanal Medicament in Asymptomatic Periapical Lesions
NCT06243601Completed
- Sponsor
- Islamabad Medical and Dental College
- Start
- Nov 2023
- Primary completion
- Aug 2024
- Modality
- Hydrogel Systems, Transdermal Patches
- Countries
- 1
01
Overview
Randomised, open-label trial of aloe vera gel in Periapical lesion (AP) (2 arms), sponsored by Islamabad Medical and Dental College. Primary endpoint: Presence or absence of signs and symptoms of the patient at 3 weeks. Started Nov 2023; status: completed.
02
Drugs
aloe vera gel
03
Conditions
Periapical lesion (AP)
Beyond the preview
Go deeper on NCT06243601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06243601.